NEOG

Conviction 95HealthcareScan · Thu, Sep 24, 2026

Neogen Corp (NEOG) closed at $13.66 (+0.66%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 72, RS Rating 97, -2.3% from its 52-week high, +95.1% year to date. Sector: Healthcare · IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES.

NEOG$13.66+0.66%

ResistanceSupportVol 14

Vol MA14 3.64M

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

NEOGEN CORPIN VITRO & IN VIVO DIAGNOSTIC SUBSTANCESwww.neogen.com ↗

Price13.66

Change+0.66%

Gap+0.66%

Rel volume1.77×

Avg volume3.05M

Avg $ vol38.48M

SMA 2012.33

SMA 5011.55

SMA 2009.81

Price vs 50+18.25%

Price vs 200+39.30%

MA stackbullish

50/200 cross—

Supertrendup · 12.47

RSI (14)72

MACD hist0.15

MACD crossbull · 6d

Stoch %K / %D79 / 83

ADX (14)46

+DI / −DI37 / 8

RSI divergence—

MACD divergence—

ATR %3.58%

ADR %3.62%

52w high13.98

52w low5.36

From 52w high-2.29%

Above 52w low+154.85%

New 52w highNo

SqueezeOff

Bollinger width25.55%

%B0.92

Donchian pos79.24%

Donchian high14.26

Donchian low11.37

AVWAP (52w high)13.74

vs AVWAP high-0.58%

AVWAP (52w low)8.66

vs AVWAP low+57.75%

OBV trendUp

Chaikin MF (20)0.12

Today vs 20d1.77×

Avg vol (14d)3.64M

Avg vol (20d)3.05M

Avg $ vol (20d)38.48M

Market cap2.98B

RS Rating97 / 99

RS 3m (vs SPY)+39.15%

RS 6m (vs SPY)+32.31%

RS line new highNo

Trend template8/8

Technical rank94.6

1 week+6.47%

1 month+17.35%

3 months+43.64%

6 months+49.13%

1 year+143.93%

YTD+95.14%

P/E-377.04

P/B1.42

P/S3.42

P/FCF36.46

EPS-0.0400

Div yield—

ROE-0.38%

ROA-0.24%

Debt/Eq0.38

Current3.82

EV/EBITDA37.88

Gross margin46.93%

Net margin-0.91%

Rev growth-2.72%

EPS growth99.28%

Price target13.00

Target upside-4.83%

Analyst ratingBuy

Institutional123.96%

Ent. value3.59B

Revenue211.2M

Net income-17M

Gross profit99M

Free cash flow81.7M

IndustryIN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

ExchangeNasdaq

Shares out217.67M

Employees1.46K

ListedWed, Aug 23, 1989

Free float216.74M

Float %99.6%

Short interest10.58M

Days to cover7.4d

Short volume30.0%

Squeeze score46 / 100

Next earningsTue, Oct 6, 2026 · after (12d)

EPS forecast$0.04 · 3 est

Last EPS vs est$0.08 vs $0.03

Last surprise+166.7% beat

Setup gradeA+

Conviction95 / 100

Pattern quality—

Tech rank94.6 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance12.61

Support11.26

Days since event—

Candle confirm—

Financials as of Sat, Feb 28, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

Setting up
Jul 1 – Jul 8
4 scans
→
Breaking out now
Jul 9
1 scan
→
Broke out
Jul 10
1 scan
→
Setting up
Sep 4 – Sep 8
2 scans

Congress activity

Disclosed STOCK Act trades in NEOG

All disclosures →

No recent disclosed trades by Congress in NEOG. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in NEOG

Insider	Side	Shares	Value	Traded	Filed
Moylan John Patrick Chief Accounting Officer · Restricted Stock Units · 2026-08-19	Tax	2.37K	$28K	2026-08-19	2026-08-20
Nassif Mikheal CEO · Restricted Stock Units · 2026-08-19	Tax	20.4K	$242K	2026-08-19	2026-08-20
Moylan John Patrick Chief Accounting Officer · Restricted Stock Units · 2026-08-14	Grant	8.58K	$100K	2026-08-14	2026-08-14
Moylan John Patrick Chief Accounting Officer · Common Stock (Right to Buy) · 2026-08-14	Grant	18.69K	—	2026-08-14	2026-08-14
Nassif Mikheal CEO · Common Stock · 2026-08-14	Grant	141.63K	$1.7M	2026-08-14	2026-08-14
Nassif Mikheal CEO · Common Stock (Right to Buy) · 2026-08-14	Grant	719.68K	—	2026-08-14	2026-08-14
Riggsbee Richard Bryan CFO · Common Stock · 2026-08-14	Grant	51.5K	$600K	2026-08-14	2026-08-14
Riggsbee Richard Bryan CFO · Common Stock (Right to Buy) · 2026-08-14	Grant	261.7K	—	2026-08-14	2026-08-14
Stacey Jennifer Evans Chief Legal Officer · Common Stock · 2026-08-14	Grant	38.63K	$450K	2026-08-14	2026-08-14
Stacey Jennifer Evans Chief Legal Officer · Common Stock (Right to Buy) · 2026-08-14	Grant	196.28K	—	2026-08-14	2026-08-14

SEC filings

EDGAR filings in NEOG · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.